Publications in collaboration with researchers from National Cancer Institute (24)

2023

  1. Evaluation of trefoil factor 3 as a non-invasive biomarker of gastric intestinal metaplasia and gastric cancer in a high-risk population

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 6, pp. 411-418

2021

  1. Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy

    Cancer Letters, Vol. 499, pp. 279-289

2010

  1. Molecular characterization of the Gγ-globin-tagtransgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer

    Prostate, Vol. 70, Núm. 6, pp. 630-645

  2. VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop

    Experimental Cell Research, Vol. 316, Núm. 4, pp. 554-567

2008

  1. Human adrenomedullin up-regulates interleukin-13 receptor α2 chain in prostate cancer in vitro and in vivo: A novel approach to sensitize prostate cancer to anticancer therapy

    Cancer Research, Vol. 68, Núm. 22, pp. 9311-9317

  2. Identification of VEGF-regulated genes associated with increased lung metastatic potential: Functional involvement of tenascin-C in tumor growth and lung metastasis

    Oncogene, Vol. 27, Núm. 40, pp. 5373-5384

2007

  1. 2-Methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: Molecular distinctions from the mammary gland of pregnant mice

    Endocrinology, Vol. 148, Núm. 3, pp. 1266-1277

  2. Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis

    International Journal of Cancer, Vol. 120, Núm. 10, pp. 2096-2109

2006

  1. Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression

    Cancer Research, Vol. 66, Núm. 7, pp. 3495-3503

2005

  1. Gene expression profiling identifies IL-13 receptor α2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin

    International Journal of Cancer, Vol. 114, Núm. 6, pp. 870-878

  2. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms

    Oncogene, Vol. 24, Núm. 5, pp. 790-800

  3. Prostate cancer and the genomic revolution: Advances using microarray analyses

    Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 576, Núm. 1-2, pp. 66-79

2004

  1. Application of Gene Expression Profiling for Validating Models of Human Breast Cancer

    Toxicologic Pathology, Vol. 32, Núm. SUPPL. 1, pp. 84-89

  2. Genomic Approaches to Understanding Mammary Tumor Progression in Transgenic Mice and Responses to Therapy

    Clinical Cancer Research

2003

  1. Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo

    Molecular and Cellular Endocrinology, Vol. 199, Núm. 1-2, pp. 179-187

2002

  1. Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice

    Cancer Research, Vol. 62, Núm. 14, pp. 3934-3938

  2. Adrenomedullin and proadrenomedullin N-terminal 20 peptide in the normal prostate and in prostate carcinoma

    Microscopy Research and Technique, Vol. 57, Núm. 2, pp. 98-104

  3. Alterations in gene expression profiles during prostate cancer progression: Functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors

    Cancer Research, Vol. 62, Núm. 18, pp. 5325-5335

  4. Chipping away at breast cancer: Insights from microarray studies of human and mouse mammary cancer

    Endocrine-Related Cancer, Vol. 9, Núm. 4, pp. 207-220

  5. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin

    International Journal of Cancer, Vol. 101, Núm. 3, pp. 224-234